French Brain Tumor DataBase: 5-Year Histological Results on 25???756 Cases, Brain Pathology, vol.8, issue.7, pp.633-644, 2011. ,
DOI : 10.1111/j.1750-3639.2011.00491.x
Trends in incidence of primary brain tumors in the United States, Neuro Oncol, vol.3, pp.141-151, 1985. ,
Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004, Neuro-Oncology, vol.12, issue.7, pp.725-735, 2004. ,
DOI : 10.1093/neuonc/noq030
Continuous growth of mean tumor diameter in a subset of grade II gliomas, Annals of Neurology, vol.54, issue.4, pp.524-528, 2003. ,
DOI : 10.1002/ana.10528
Primary brain tumours in adults, The Lancet, vol.379, issue.9830, pp.1984-1996, 2012. ,
DOI : 10.1016/S0140-6736(11)61346-9
Adjuvant Procarbazine, Lomustine, and Vincristine Improves Progression-Free Survival but Not Overall Survival in Newly Diagnosed Anaplastic Oligodendrogliomas and Oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial, Journal of Clinical Oncology, vol.24, issue.18, pp.2715-2722, 2006. ,
DOI : 10.1200/JCO.2005.04.6078
Long-term Prognostic Assessment of 185 Newly Diagnosed Gliomas--Grade III Glioma Showed Prognosis Comparable to That of Grade II Glioma, Japanese Journal of Clinical Oncology, vol.38, issue.11, pp.730-733, 2008. ,
DOI : 10.1093/jjco/hyn099
Interobserver reproducibility among neuropathologists and surgical pathologists in fibrillary astrocytoma grading, Journal of the Neurological Sciences, vol.175, issue.1, pp.33-39, 2000. ,
DOI : 10.1016/S0022-510X(00)00274-4
Prognostic value of initial magnetic resonance imaging growth rates for World Health Organization grade II gliomas, Annals of Neurology, vol.22, issue.3, pp.380-383, 2006. ,
DOI : 10.1002/ana.20946
URL : https://hal.archives-ouvertes.fr/inserm-00163977
Advances in imaging low-grade gliomas, Adv Tech Stand Neurosurg, vol.35, pp.1-34, 2010. ,
DOI : 10.1007/978-3-211-99481-8_1
Quantitatively Determined Survivin Expression Levels Are of Prognostic Value in Human Gliomas, Journal of Clinical Oncology, vol.20, issue.4, pp.1063-1068, 2002. ,
DOI : 10.1200/JCO.2002.20.4.1063
Proliferating cell nuclear antigen and Ki-67 immunohistochemistry of oligodendrogliomas with special reference to prognosis, Cancer, vol.52, issue.10, pp.1809-1813, 1995. ,
DOI : 10.1002/1097-0142(19951115)76:10<1809::AID-CNCR2820761020>3.0.CO;2-I
Histopathologic and immunohistochemical prognostic factors in malignant gliomas, Current Opinion in Oncology, vol.9, issue.3, pp.230-234, 1997. ,
DOI : 10.1097/00001622-199709030-00003
Gene Expression-Based Molecular Diagnostic System for Malignant Gliomas Is Superior to Histological Diagnosis, Clinical Cancer Research, vol.13, issue.24, pp.7341-7356, 2007. ,
DOI : 10.1158/1078-0432.CCR-06-2789
Gene expression-based classification of malignant gliomas correlates better with survival than histological classification, Cancer Res, vol.63, pp.1602-1607, 2003. ,
Unsupervised Analysis of Transcriptomic Profiles Reveals Six Glioma Subtypes, Cancer Research, vol.69, issue.5, pp.2091-2099, 2009. ,
DOI : 10.1158/0008-5472.CAN-08-2100
Intrinsic Gene Expression Profiles of Gliomas Are a Better Predictor of Survival than Histology, Cancer Research, vol.69, issue.23, pp.9065-9072, 2009. ,
DOI : 10.1158/0008-5472.CAN-09-2307
Gene Expression Profiling of Gliomas Strongly Predicts Survival, Cancer Research, vol.64, issue.18, pp.6503-6510, 2004. ,
DOI : 10.1158/0008-5472.CAN-04-0452
Improved grading and survival prediction of human astrocytic brain tumors by artificial neural network analysis of gene expression microarray data, Molecular Cancer Therapeutics, vol.7, issue.5, pp.1013-1024, 2008. ,
DOI : 10.1158/1535-7163.MCT-07-0177
The Proneural Molecular Signature Is Enriched in Oligodendrogliomas and Predicts Improved Survival among Diffuse Gliomas, PLoS ONE, vol.65, issue.9, p.12548, 2010. ,
DOI : 10.1371/journal.pone.0012548.s011
A 4-Gene Signature Associated with Clinical Outcome in High-Grade Gliomas, Clinical Cancer Research, vol.17, issue.2, pp.317-327, 2011. ,
DOI : 10.1158/1078-0432.CCR-10-1126
URL : https://hal.archives-ouvertes.fr/inserm-00545436
Modeling risk stratification in human cancer, Bioinformatics, vol.29, issue.9, pp.1149-1157, 2013. ,
DOI : 10.1093/bioinformatics/btt124
Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma, Oncotarget, vol.3, issue.10, pp.1194-1203, 2012. ,
DOI : 10.18632/oncotarget.689
Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile, Molecular Cancer, vol.7, issue.1, p.41, 2008. ,
DOI : 10.1186/1476-4598-7-41
Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells, Nature, vol.156, issue.7120, pp.761-765, 2006. ,
DOI : 10.1038/nature05349
The divergent DSL ligand Dll3 does not activate Notch signaling but cell autonomously attenuates signaling induced by other DSL ligands, The Journal of Cell Biology, vol.16, issue.6, pp.983-992, 2005. ,
DOI : 10.1002/gene.10081
Notch1 expression is upregulated in glioma and is associated with tumor progression, Journal of Clinical Neuroscience, vol.18, issue.3, pp.387-390, 2011. ,
DOI : 10.1016/j.jocn.2010.07.131
Notch1 is an independent prognostic factor for patients with glioma, Journal of Surgical Oncology, vol.53, issue.8, pp.813-817, 2011. ,
DOI : 10.1002/jso.21851
Differential Distribution of erbB Receptors in Human Glioblastoma Multiforme: Expression of erbB3 in CD133-Positive Putative Cancer Stem Cells, Journal of Neuropathology & Experimental Neurology, vol.69, issue.6, pp.606-622, 2010. ,
DOI : 10.1097/NEN.0b013e3181e00579
URL : https://hal.archives-ouvertes.fr/inserm-00487086
Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: a revelation by parallel gene expression profiling, Cancer Res, vol.59, pp.4228-4232, 1999. ,
Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma, Cancer Res, vol.62, pp.4364-4368, 2002. ,
Radiogenomic Mapping of Edema/Cellular Invasion MRI-Phenotypes in Glioblastoma Multiforme, PLoS ONE, vol.7, issue.10, p.25451, 2011. ,
DOI : 10.1371/journal.pone.0025451.s002
Integrated Array-Comparative Genomic Hybridization and Expression Array Profiles Identify Clinically Relevant Molecular Subtypes of Glioblastoma, Cancer Research, vol.65, issue.5, pp.1678-1686, 2005. ,
DOI : 10.1158/0008-5472.CAN-04-2921
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis, Cancer Cell, vol.9, issue.3, pp.157-173, 2006. ,
DOI : 10.1016/j.ccr.2006.02.019
Periostin expression and epithelial-mesenchymal transition in cancer: a review and an update, Virchows Archiv, vol.1775, issue.Pt 1, pp.465-475, 2011. ,
DOI : 10.1007/s00428-011-1151-5
The Proneural Molecular Signature Is Enriched in Oligodendrogliomas and Predicts Improved Survival among Diffuse Gliomas, PLoS ONE, vol.65, issue.9, p.12548, 2010. ,
DOI : 10.1371/journal.pone.0012548.s011
The Accuracy of Survival Time Prediction for Patients with Glioma Is Improved by Measuring Mitotic Spindle Checkpoint Gene Expression, PLoS ONE, vol.360, issue.10, p.25631, 2011. ,
DOI : 10.1371/journal.pone.0025631.s010
Phosphorylation and Stabilization of HURP by Aurora-A: Implication of HURP as a Transforming Target of Aurora-A, Molecular and Cellular Biology, vol.25, issue.14, pp.5789-5800, 2005. ,
DOI : 10.1128/MCB.25.14.5789-5800.2005
Multiple faces of FoxM1 transcription factor, Cell Cycle, vol.62, issue.3, pp.396-405, 2011. ,
DOI : 10.1158/0008-5472.CAN-10-2004
Nek2 kinase in chromosome instability and cancer, Cancer Letters, vol.237, issue.2, pp.155-166, 2006. ,
DOI : 10.1016/j.canlet.2005.06.017
Polo-like kinases and oncogenesis, Oncogene, vol.24, issue.2, pp.267-276, 2005. ,
DOI : 10.1038/sj.onc.1208273
Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme, Proceedings of the National Academy of Sciences, vol.102, issue.16, pp.5814-5819, 2005. ,
DOI : 10.1073/pnas.0402870102
Impaired Angiogenesis, Delayed Wound Healing and Retarded Tumor Growth in Perlecan Heparan Sulfate-Deficient Mice, Cancer Research, vol.64, issue.14, pp.4699-4702, 2004. ,
DOI : 10.1158/0008-5472.CAN-04-0810
Expression of vascular Notch ligands Delta-like 4 and Jagged-1 in glioblastoma, Histopathology, vol.68, issue.5, pp.740-747, 2012. ,
DOI : 10.1111/j.1365-2559.2011.04138.x
Isolation of mineralizing Nestin+ Nkx6.1+ vascular muscular cells from the adult human spinal cord, BMC Neuroscience, vol.12, issue.1, p.99, 2011. ,
DOI : 10.1016/S1044-7431(03)00161-1
URL : https://hal.archives-ouvertes.fr/inserm-00637318
Tenascin-C expression by angiogenic vessels in human astrocytomas and by human brain endothelial cells in vitro, Cancer Res, vol.56, pp.182-189, 1996. ,
Hallmarks of Cancer: The Next Generation, Cell, vol.144, issue.5, pp.646-674, 2011. ,
DOI : 10.1016/j.cell.2011.02.013
In Vivo Expression of Insulin-Like Growth Factor-Binding Protein-2 in Human Gliomas Increases with the Tumor Grade, Endocrinology, vol.142, issue.4, pp.1652-1658, 2001. ,
DOI : 10.1210/en.142.4.1652
YKL-40 Is a Differential Diagnostic Marker for Histologic Subtypes of High-Grade Gliomas, Clinical Cancer Research, vol.11, issue.6, pp.2258-2264, 2005. ,
DOI : 10.1158/1078-0432.CCR-04-1601
Roadmap for Developing and Validating Therapeutically Relevant Genomic Classifiers, Journal of Clinical Oncology, vol.23, issue.29, pp.7332-7341, 2005. ,
DOI : 10.1200/JCO.2005.02.8712
Rembrandt: Helping Personalized Medicine Become a Reality through Integrative Translational Research, Molecular Cancer Research, vol.7, issue.2, pp.157-167, 2009. ,
DOI : 10.1158/1541-7786.MCR-08-0435
The 2007 WHO Classification of Tumours of the Central Nervous System, Acta Neuropathologica, vol.64, issue.2, pp.97-109, 2007. ,
DOI : 10.1007/s00401-007-0243-4
Oligodendroglial Neoplasms: Current Concepts, Misconceptions, and Folklore, Advances in Anatomic Pathology, vol.8, issue.4, pp.183-199, 2001. ,
DOI : 10.1097/00125480-200107000-00001
Oligodendrogliomas. Part II: A new grading system based on morphological and imaging criteria, Journal of Neuro-Oncology, vol.34, issue.1, pp.61-78, 1997. ,
DOI : 10.1023/A:1005759220434
Oligodendrogliomas. Part I: Patterns of growth, histological diagnosis, clinical and imaging correlations: a study of 153 cases, Journal of Neuro-Oncology, vol.34, issue.1, pp.37-59, 1997. ,
DOI : 10.1023/A:1005707203596
Identification of CGA as a novel estrogen receptor-responsive gene in breast cancer: an outstanding candidate marker to predict the response to endocrine therapy, Cancer Res, vol.61, pp.1652-1658, 2001. ,
Controlling the False Discovery Rate: a practical and powerful approach to multiple testing, Journal of the Royal Statistical Society Series B, vol.57, pp.289-300, 1995. ,
Bioconductor: open software development for computational biology and bioinformatics, Genome Biology, vol.5, issue.10, p.80, 2004. ,
DOI : 10.1186/gb-2004-5-10-r80
A Model-Based Background Adjustment for Oligonucleotide Expression Arrays, Journal of the American Statistical Association, vol.99, issue.468, pp.909-917, 2004. ,
DOI : 10.1198/016214504000000683
Gene Expression Profiling in Multiple Myeloma--Reporting of Entities, Risk, and Targets in Clinical Routine, Clinical Cancer Research, vol.17, issue.23, pp.7240-7247, 2011. ,
DOI : 10.1158/1078-0432.CCR-11-1628
Microarray Based Diagnosis Profits from Better Documentation of Gene Expression Signatures, PLoS Computational Biology, vol.19, issue.2, p.22, 2008. ,
DOI : 10.1371/journal.pcbi.0040022.sg008
Diagnosis of multiple cancer types by shrunken centroids of gene expression, Proceedings of the National Academy of Sciences, vol.99, issue.10, pp.6567-6572, 2002. ,
DOI : 10.1073/pnas.082099299
Modeling Survival Data: Extending the Cox Model, 2000. ,
DOI : 10.1007/978-1-4757-3294-8